Venn Life Sciences Holdings PLC

Receive alerts
Market Cap:
52 weeks high
52 weeks low

In brief

Venn Life Sciences is a European Contract Research Organisation providing drug development, clinical trial management solutions and resourcing solutions to pharmaceutical, biotechnology, medical device and academic organisations. Venn as it is today was founded in 2007, however our history dates back to 1989 when our first offices opened in Paris, France. Since then Venn has grown to have offices across the Netherlands, Germany, the UK, Ireland and a second office in France specialising in Biometry.

Our reach has also grown globally with resources in a host of countries working on clinical studies for Venn. Our teams specialise in multi-site cross cultural clinical trials with unique knowledge of local and EU regulations. Over our 25 year history we have built up substantial therapeutic and study experience, contributing to the efficient management of sites, budgets and communication channels with all parties involved. Venn is renowned for its hands-on approach and consistent delivery of high quality work on time and on budget.

Venn leverages the expertise and experience of its highly-skilled, multi-disciplinary workforce to accelerate development of medicinal products, either small molecules or biologics, herbal medicines or nutraceuticals. This unique concentration of multidisciplinary experts – combined with a direct and pragmatic approach – presents sponsors with flexible service options to cope with fluctuations in business requirements.

Venn Life Sciences is traded in the NEX Exchange HERE